Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL CLINICAL LABORATORY TESTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VOLUME
2.2.11 VENDOR SHARE ANALYSIS
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL CLINICAL LABORATORY TESTS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTLE ANALYSIS
5.2 PORTER’S FIVE FORCES
6 REGULATORY SCENARIO
7 INDUSTRY INSIGHTS
8 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISION FOR MANUFACTURERS
8.5 CONCLUSION
9 GLOBAL CLINICAL LABORATORY TESTS MARKET, BY TEST
9.1 OVERVIEW
9.2 CLINICAL
9.3 COMPLETE COMPREHENSIVE TEST OR COMPLETE BODY TEST
9.4 COMPLETE BODY COUNT (CBC)
9.5 BASIC METABOLIC PANEL (BMP)
9.6 HGB/HCT
9.7 HBA1C TESTS
9.8 BUN CREATININE TESTS
9.9 ELECTROLYTES TESTS
9.1 RENAL PANEL TESTS
9.11 LIPID PANEL TESTS
9.12 HEPATITIS
9.13 BILE DUCT OBSTRUCTION
9.14 LIVER PANNEL TESTS
9.14.1 HEPATITIS
9.14.2 BILE DUCT OBSTRUCTION
9.14.3 LIVER CIRRHOSIS
9.14.4 LIVER CANCER
9.14.5 BONE DISEASE
9.14.6 AUTOIMMUNE DISORDERS
9.14.7 OTHERS
9.15 BONE DISEASE TEST
9.16 AUTOIMMUNE DISORDERS TEST
9.17 OTHERS
10 GLOBAL CLINICAL LABORATORY TESTS MARKET, BY TYPE
10.1 OVERVIEW
10.2 ROUTINE
10.3 SPECIALTY
11 GLOBAL CLINICAL LABORATORY TESTS MARKET, BY APPLICATIONS
11.1 OVERVIEW
11.2 PARASITOLOGY
11.3 HEMATOLOGY
11.4 VIROLOGY
11.5 TOXICOLOGY
11.6 IMMUNOLOGY/SEROLOGY
11.7 URINALYSIS
11.8 OTHERS
12 GLOBAL CLINICAL LABORATORY TESTS MARKET, BY SPECIALTY
12.1 ORGAN FUNCTION TESTS
12.1.1 KIDNEY
12.1.1.1. CREATININE
12.1.1.2. UREA
12.1.1.3. URIC ACID
12.1.1.4. OTHERS
12.1.2 LIVER
12.1.2.1. AST
12.1.2.2. ALT
12.1.2.3. AST & ALT
12.1.2.4. LDH
12.1.2.5. BILIRUBIN
12.1.2.6. OTHERS
12.1.3 PANCREAS
12.1.3.1. AMYLASE
12.1.3.2. LIPASE
12.1.4 CARDIOVASCULAR
12.1.4.1. TOTAL CHOLESTEROL
12.1.4.2. TRIGLYCERIDES
12.1.4.3. HDL-CHOLESTEROL
12.1.4.4. LDL-CHOLESTEROL
12.1.5 OTHERS
12.2 HORMONE LEVEL TESTS
12.2.1 CORTISOL
12.2.2 TESTOSTERONE
12.2.3 FOLLICLE-STIMULATING HORMONE
12.2.4 LUTEINIZING HORMONE (LH)
12.2.5 ESTRADIOL
12.2.6 PROGESTERONE
12.2.7 PROLACTIN
12.2.8 OTHERS
12.3 SCREENING TESTS
12.3.1 COMPLETE BLOOD COUNT
12.3.1.1. HAEMOGLOBIN
12.3.1.2. RBC & HEMATOCRIT (HCT)
12.3.1.3. WBC (WHITE BLOOD CELLS, LEUKOCYTES)
12.3.1.4. PLATELET
12.3.1.5. OTHERS
12.3.2 PAP SMEAR
12.3.3 URINALYSIS
12.3.4 HGB/HCT TESTING
12.3.5 OTHERS
12.4 INFECTIOUS DISEASE TESTS
12.4.1 FLU PANEL TEST
12.4.2 MONONUCLEOSIS
12.4.3 OTHERS
12.5 SEXUALLY TRANSMITTED INFECTION TESTS
12.5.1 CHLAMYDIA
12.5.2 GONORRHEA
12.5.3 HIV
12.5.4 OTHERS
12.6 CANCER TESTS
12.6.1 LIVER CANCER
12.6.1.1. CA 125
12.6.1.2. PSA,
12.6.1.3. AFP
12.6.1.4. CEA
12.6.1.5. OTHERS
12.6.2 PROSTATE CANCER
12.6.3 OVARIAN CANCER
12.6.4 OTHERS
12.7 AUTOIMMUNE TESTS
12.8 OTHERS
13 GLOBAL CLINICAL LABORATORY TESTS MARKET, BY END USERS
13.1 OVERVIEW
13.2 INDEPENDENT & REFERENCE LABORATORIES
13.3 HOSPITAL-BASED LABORATORIES
13.4 CLINIC-BASED LABORATORIES
13.5 CENTRAL/INDEPENDENT LABORATORIES
13.6 PHYSICIAN OFFICE-BASED LABORATORIES
13.7 OTHERS
14 GLOBAL CLINICAL LABORATORY TESTS MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14.5 MERGERS & ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT & APPROVALS
14.7 EXPANSIONS
14.8 REGULATORY CHANGES
14.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 GLOBAL CLINICAL LABORATORY TESTS MARKET, BY GEOGRAPHY
GLOBAL CLINICAL LABORATORY TESTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
15.2 EUROPE
15.2.1 GERMANY
15.2.2 FRANCE
15.2.3 U.K.
15.2.4 HUNGARY
15.2.5 LITHUANIA
15.2.6 AUSTRIA
15.2.7 IRELAND
15.2.8 NORWAY
15.2.9 POLAND
15.2.10 ITALY
15.2.11 SPAIN
15.2.12 RUSSIA
15.2.13 TURKEY
15.2.14 NETHERLANDS
15.2.15 SWITZERLAND
15.2.16 REST OF EUROPE
15.3 ASIA-PACIFIC
15.3.1 JAPAN
15.3.2 CHINA
15.3.3 SOUTH KOREA
15.3.4 INDIA
15.3.5 SINGAPORE
15.3.6 THAILAND
15.3.7 INDONESIA
15.3.8 MALAYSIA
15.3.9 PHILIPPINES
15.3.10 AUSTRALIA
15.3.11 NEW ZEALAND
15.3.12 VIETNAM
15.3.13 TAIWAN
15.3.14 REST OF ASIA-PACIFIC
15.4 SOUTH AMERICA
15.4.1 BRAZIL
15.4.2 ARGENTINA
15.4.3 PERU
15.4.4 REST OF SOUTH AMERICA
15.5 MIDDLE EAST AND AFRICA
15.5.1 SOUTH AFRICA
15.5.2 SAUDI ARABIA
15.5.3 UAE
15.5.4 EGYPT
15.5.5 KUWAIT
15.5.6 ISRAEL
15.5.7 REST OF MIDDLE EAST AND AFRICA
15.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
16 GLOBAL CLINICAL LABORATORY TESTS MARKET, SWOT AND DBMR ANALYSIS
17 GLOBAL CLINICAL LABORATORY TESTS MARKET, COMPANY PROFILE
17.1 ABBOTT
17.1.1 COMPANY OVERVIEW
17.1.2 GEOGRAPHIC PRESENCE
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 ARUP LABORATORIES
17.2.1 COMPANY OVERVIEW
17.2.2 GEOGRAPHIC PRESENCE
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENTS
17.3 OPKO HEALTH, INC.
17.3.1 COMPANY OVERVIEW
17.3.2 GEOGRAPHIC PRESENCE
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 BIOSCIENTIA HEALTHCARE GMBH
17.4.1 COMPANY OVERVIEW
17.4.2 GEOGRAPHIC PRESENCE
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 CHARLES RIVER LABORATORIES
17.5.1 COMPANY OVERVIEW
17.5.2 GEOGRAPHIC PRESENCE
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 NEOGENOMICS LABORATORIES
17.6.1 COMPANY OVERVIEW
17.6.2 GEOGRAPHIC PRESENCE
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENTS
17.7 GENOPTIX, INC.
17.7.1 COMPANY OVERVIEW
17.7.2 GEOGRAPHIC PRESENCE
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 HEALTHSCOPE
17.8.1 COMPANY OVERVIEW
17.8.2 GEOGRAPHIC PRESENCE
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENTS
17.9 THE LABORATORY GLASSWARE CO.
17.9.1 COMPANY OVERVIEW
17.9.2 GEOGRAPHIC PRESENCE
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 LABORATORY CORPORATION OF AMERICA® HOLDINGS
17.10.1 COMPANY OVERVIEW
17.10.2 GEOGRAPHIC PRESENCE
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 FRESENIUS MEDICAL CARE AG & CO. KGAA
17.11.1 COMPANY OVERVIEW
17.11.2 GEOGRAPHIC PRESENCE
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENTS
17.12 QIAGEN
17.12.1 COMPANY OVERVIEW
17.12.2 GEOGRAPHIC PRESENCE
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 QUEST DIAGNOSTICS INCORPORATED
17.13.1 COMPANY OVERVIEW
17.13.2 GEOGRAPHIC PRESENCE
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENTS
17.14 SIEMENS HEALTHCARE PRIVATE LIMITED
17.14.1 COMPANY OVERVIEW
17.14.2 GEOGRAPHIC PRESENCE
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENTS
17.15 TULIP DIAGNOSTICS (P) LTD.
17.15.1 COMPANY OVERVIEW
17.15.2 GEOGRAPHIC PRESENCE
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SONIC HEALTHCARE LIMITED
17.16.1 COMPANY OVERVIEW
17.16.2 GEOGRAPHIC PRESENCE
17.16.3 PRODUCT PORTFOLIO
17.16.4 RECENT DEVELOPMENTS
17.17 MERCK KGAA
17.17.1 COMPANY OVERVIEW
17.17.2 GEOGRAPHIC PRESENCE
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENTS
17.18 LABCORP
17.18.1 COMPANY OVERVIEW
17.18.2 GEOGRAPHIC PRESENCE
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS
17.19 SPECTRA LABORATORIES
17.19.1 COMPANY OVERVIEW
17.19.2 GEOGRAPHIC PRESENCE
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENTS
17.2 DAVITA HEALTHCARE PARTNERS
17.20.1 COMPANY OVERVIEW
17.20.2 GEOGRAPHIC PRESENCE
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 ACM MEDICAL LABORATORY
17.21.1 COMPANY OVERVIEW
17.21.2 GEOGRAPHIC PRESENCE
17.21.3 PRODUCT PORTFOLIO
17.21.4 RECENT DEVELOPMENTS
17.22 CEREBA HEALTHCARE
17.22.1 COMPANY OVERVIEW
17.22.2 GEOGRAPHIC PRESENCE
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
18 RELATED REPORTS
19 CONCLUSION
20 QUESTIONNAIRE
21 ABOUT DATA BRIDGE MARKET RESEARCH
